MS vs NKE: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and NIKE, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-17.
Morgan Stanley · Financial Services
$206.27
+15.9% upside to fair value
Med Conviction
Grade C
VS
NIKE, Inc. · Consumer Cyclical
$35.78
+9.9% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
MS has more upside to fair value
(+15.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
NKE |
| Current Price |
$206.27 |
$35.78 |
| Fair Value Estimate |
$239.00 |
$39.33 |
| Upside to Fair Value |
+15.9%
|
+9.9%
|
| Market Cap |
$325.4B |
$53.0B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
23.5x
|
12.0x
|
| Price / Sales |
2.6x
|
1.1x
|
| Price / FCF |
—
|
24.3x
|
| Revenue Growth YoY |
+22.4%
|
-1.1%
|
| Gross Margin |
59.7%
|
42.9%
|
| Operating Margin |
20.7%
|
8.2%
|
| Return on Equity |
18.1%
|
22.0%
|
| Dividend Yield |
2.01% |
4.58% |
| FCF Yield |
—
|
4.12%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Morgan Stanley is a diversified capital-markets and wealth-management franchise spanning institutional securities, advisor-led and self-directed wealth, workplace services, and investment management. Business quality is solid but inherently cyclical: it combines $8.084 trillion of wealth client assets and $2.004 trillion of investment-management AUM/AUS with a strengthening 15.5% institutional pe…
NIKE designs, markets and distributes athletic footwear, apparel and equipment through the Nike, Jordan and Converse brands, supported by global athlete marketing, valuable intellectual property and a broad wholesale and owned-digital network. Business quality is medium: its brand moat and 22.0% ROE remain meaningful, but the moat is narrowing amid intense competition, weak direct sales and uneve…
Accumulation Zones
| Metric |
MS |
NKE |
| Zone Low |
$179.25 |
$29.50 |
| Zone High |
$203.15 |
$33.43 |
| In Buy Zone? |
No
|
No
|